Suppr
超能文献

The gynecologic effects of lasofoxifene, an estrogen agonist/antagonist, in postmenopausal women.

作者信息

Archer David F

出版信息

Menopause. 2011 Jan;18(1):6-7. doi: 10.1097/gme.0b013e318203a46b.

DOI:10.1097/gme.0b013e318203a46b

PMID:21173718

Abstract

摘要

相似文献

The gynecologic effects of lasofoxifene, an estrogen agonist/antagonist, in postmenopausal women.

Menopause. 2011 Jan;18(1):6-7. doi: 10.1097/gme.0b013e318203a46b.

Another selective estrogen-receptor modulator for osteoporosis.

N Engl J Med. 2010 Feb 25;362(8):752-4. doi: 10.1056/NEJMe0912847.

Lasofoxifene for postmenopausal women with osteoporosis.

N Engl J Med. 2010 Jun 10;362(23):2227-8; author reply 2228-9.

[Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies].

Clin Calcium. 2004 Oct;14(10):85-93.

Not all SERMs are created equal.

Menopause. 2006 May-Jun;13(3):325-7. doi: 10.1097/01.gme.0000222332.31101.42.

Lasofoxifene in postmenopausal women with osteoporosis.

N Engl J Med. 2010 Feb 25;362(8):686-96. doi: 10.1056/NEJMoa0808692.

Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.

Menopause. 2010 May-Jun;17(3):642-53. doi: 10.1097/gme.0b013e3181c4f1d6.

Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.

Menopause. 2006 May-Jun;13(3):377-86. doi: 10.1097/01.gme.0000188736.69617.4f.

Use of SERMs for treatment in postmenopausal women.

J Steroid Biochem Mol Biol. 2014 Jul;142:142-54. doi: 10.1016/j.jsbmb.2013.12.011. Epub 2013 Dec 25.

Lasofoxifene for postmenopausal women with osteoporosis.

N Engl J Med. 2010 Jun 10;362(23):2228; author reply 2228-9.

引用本文的文献

Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells.

Front Immunol. 2022 Jul 6;13:889950. doi: 10.3389/fimmu.2022.889950. eCollection 2022.

Selective Estrogen Receptor Modulators.

Asian Spine J. 2016 Aug;10(4):787-91. doi: 10.4184/asj.2016.10.4.787. Epub 2016 Aug 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The gynecologic effects of lasofoxifene, an estrogen agonist/antagonist, in postmenopausal women.

Menopause. 2011 Jan;18(1):6-7. doi: 10.1097/gme.0b013e318203a46b.

Another selective estrogen-receptor modulator for osteoporosis.

N Engl J Med. 2010 Feb 25;362(8):752-4. doi: 10.1056/NEJMe0912847.

Lasofoxifene for postmenopausal women with osteoporosis.

N Engl J Med. 2010 Jun 10;362(23):2227-8; author reply 2228-9.

[Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies].

Clin Calcium. 2004 Oct;14(10):85-93.

Not all SERMs are created equal.

Menopause. 2006 May-Jun;13(3):325-7. doi: 10.1097/01.gme.0000222332.31101.42.

Lasofoxifene in postmenopausal women with osteoporosis.

N Engl J Med. 2010 Feb 25;362(8):686-96. doi: 10.1056/NEJMoa0808692.

Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.

Menopause. 2010 May-Jun;17(3):642-53. doi: 10.1097/gme.0b013e3181c4f1d6.

Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.

Menopause. 2006 May-Jun;13(3):377-86. doi: 10.1097/01.gme.0000188736.69617.4f.

Use of SERMs for treatment in postmenopausal women.

J Steroid Biochem Mol Biol. 2014 Jul;142:142-54. doi: 10.1016/j.jsbmb.2013.12.011. Epub 2013 Dec 25.

Lasofoxifene for postmenopausal women with osteoporosis.

N Engl J Med. 2010 Jun 10;362(23):2228; author reply 2228-9.

引用本文的文献

Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells.

Front Immunol. 2022 Jul 6;13:889950. doi: 10.3389/fimmu.2022.889950. eCollection 2022.

Selective Estrogen Receptor Modulators.

Asian Spine J. 2016 Aug;10(4):787-91. doi: 10.4184/asj.2016.10.4.787. Epub 2016 Aug 16.

Suppr超能文献

The gynecologic effects of lasofoxifene, an estrogen agonist/antagonist, in postmenopausal women.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译